CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Thursday - Broadcom (NASDAQ:AVGO), D
Analysts updated price targets for several companies. HC Wainwright cut Ultragenyx's (RARE) target to $25. Needham raised UiPath's (PATH) target to $22. BTIG increased Netskope's (NTSK) target to $18 and Snowflake's (SNOW) to $424. Needham also raised Magnite's (MGNI) target to $30. Cantor Fitzgerald boosted Broadcom's (AVGO) target to $600. Baird increased CrowdStrike's (CRWD) target to $235. Rothschild & Co raised Moderna's (MRNA) target to $81 but downgraded it. B of A cut Sonoco's (SON) targ
How this was made
The 30-second read
Why it matters
Overall impact is modest as the revisions are incremental and lack fresh catalysts.
Market read
Analyst target revisions provide limited trading signals; most changes are modest and likely already reflected in prices.
What to watch
No new fundamental catalyst accompanies the revisions, reducing actionable insight.
Background
The article aggregates recent analyst price target updates for a set of U.S.-listed companies.
Ticker impact
HC Wainwright cut Ultragenyx price target to $25, indicating lowered expectations.
Modest decline if market reacts.
Analyst target cut suggests weaker outlook; no new catalyst beyond the downgrade.
Needham raised UiPath price target to $22, signaling improved outlook.
Small rally if investors follow the upgrade.
Target increase reflects bullish view but lacks a concrete catalyst.
BTIG boosted Netskope price target to $18, a modest increase.
Little price movement expected.
Small target change; market likely already priced in.
BTIG raised Snowflake price target to $424 from $340.
Moderate rally if investors act on the higher target.
Significant target lift suggests strong confidence, but no new fundamental data.
Needham increased Magnite price target to $30 from $25.
Small upside possible.
Target raise modest; limited market impact.
Cantor Fitzgerald boosted Broadcom price target to $600 from $525.
Potential price gain if market follows.
Target increase reflects optimism but lacks a fresh catalyst.
Baird raised CrowdStrike price target to $235 from $230.
Minor upside possible.
Small target bump; no new material news.
Rothschild raised Moderna price target to $81 from $40 but downgraded to Sell.
Unclear direction; market may stay flat.
Target increase offset by downgrade; ambiguous impact.
Market effects
Analyst target revisions across tech and biotech may slightly shift sector sentiment.
U.S. equities may see modest volatility in the affected stocks.
Limited; primarily U.S. market focus.
Counterpoint
Target changes are minor and may already be priced in; traders could ignore.
Key entities
- analyst_firmHC Wainwright
Provided price target cut for Ultragenyx.
- analyst_firmNeedham
Raised targets for UiPath, Magnite.
- analyst_firmBTIG
Adjusted targets for Netskope, Snowflake.
- analyst_firmCantor Fitzgerald
Boosted Broadcom target.
- analyst_firmBaird
Raised CrowdStrike target.
